Medidata general manager and SVP for the EMEA region, Christian Hebenstreit spoke recently with In Vivo about how technology is changing the speed and quality of data analysis for clinical trials. Thanks to new advances in AI and machine learning, ideas that were mere buzzwords as recently as three years ago are now a reality, transforming clinical trials data, and influencing clinical trial decision making. Access these unique insights into the changing face of clinical trials data and what it means for the future of the industry in this essential In Vivo article.